FAQ

GFB 111

Known as: GFB-111, GFB111 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2000-2000
024620002000

Related topics

Related topics

1 relation

Broader (1)

Cyclic Peptides

Related mentions per year

Related mentions per year

1955-2018
1960198020002020
GFB 111
Cyclic Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice
We have designed a molecule, GFB-111, that binds to platelet-derived growth factor (PDGF), prevents it from binding to its… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
Review
2000
Review
2000
Design of growth factor antagonists with antiangiogenic and antitumor properties
This review describes our recent efforts in the development of novel therapies for cancer. Our primary approach is to design… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2000
2000
Protein identification at nanomolar concentration
promising area involves the design of smallmolecule inhibitors of growth factors active in malignancies. PDGF and its receptors… (More)
Is this relevant?
2000
2000
A FACS screen for improving enzymes
promising area involves the design of smallmolecule inhibitors of growth factors active in malignancies. PDGF and its receptors… (More)
Is this relevant?
2000
2000
Synthetic transcriptional activators
promising area involves the design of smallmolecule inhibitors of growth factors active in malignancies. PDGF and its receptors… (More)
Is this relevant?
2000
2000
A small-molecule PDGF inhibitor
promising area involves the design of smallmolecule inhibitors of growth factors active in malignancies. PDGF and its receptors… (More)
Is this relevant?